Patterns of HIV Treatment Preferences Among People With Diverse Demographic, Social, and Behavioral Characteristics Who Are Living With HIV in the United States
Patterns of HIV medication preference can inform development of new forms of HIV therapy products because the majority of patients do not prefer the currently most available treatment option of daily oral tablets. Looking beyond population-level preferences and into similar groups of people with HIV increases the ability to develop patient-centered products to fill gaps in care and increase treatment effectiveness.
Authors
- Elizabeth S. Russell (ORCID: https://orcid.org/0000-0001-7462-9280)
- Yan Song (ORCID: https://orcid.org/0000-0002-7566-2813)
- Mo Zhou (ORCID: https://orcid.org/0000-0003-3538-7666)
- T. Christopher Mast (ORCID: https://orcid.org/0000-0003-2396-7233)
- Narquis Barak
- Yipeng Gao (ORCID: https://orcid.org/0000-0001-5917-1005)
Institutions
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Ochsner Health System (US)
- Merck KGaA, Darmstadt (Germany) (DE)
- Ochsner Medical Center (US)
- Analysis Group (United States) (US)
Publication Details
- Journal
- JAIDS Journal of Acquired Immune Deficiency Syndromes
- Published
- 2024-08-15
- DOI
- https://doi.org/10.1097/qai.0000000000003509
- Citations
- 2
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.78